logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

BaricitinibHerpes zoster, rebound effect in the form of flare of granuloma annulare and off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2023年 / 1977卷 / 1期
关键词:
D O I:
10.1007/s40278-023-47144-8
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:70 / 70
相关论文
共 50 条
  • [41] FavipiravirNephrotoxicity following off-label use: case report
    Reactions Weekly, 2022, 1929 (1) : 283 - 283
  • [42] DexamethasoneAspergillosis secondary to off-label use: case report
    Reactions Weekly, 2022, 1935 (1) : 177 - 177
  • [43] MirtazapineTachyphylaxis following off-label use: case report
    Reactions Weekly, 2018, 1703 (1) : 182 - 182
  • [44] RisdiplamPneumonia following off-label use: case report
    Reactions Weekly, 2023, 1950 (1) : 348 - 348
  • [45] CanagliflozinFanconi syndrome and off-label use: case report
    Reactions Weekly, 2020, 1787 (1) : 130 - 130
  • [46] RivoceranibNeurotoxicity following an off-label use: case report
    Reactions Weekly, 2018, 1702 (1) : 232 - 232
  • [47] HydroxychloroquineLack of efficacy and off-label use: case report
    Reactions Weekly, 2022, 1925 (1) : 264 - 264
  • [48] PanitumumabSkin rash in an off-label use : case report
    Reactions Weekly, 2016, 1610 (1) : 117 - 117
  • [49] AzithromycinLack of efficacy and off-label use: case report
    Reactions Weekly, 2021, 1878 (1) : 110 - 110
  • [50] ImatinibVarious toxicities and off-label use: case report
    Reactions Weekly, 2023, 1945 (1) : 279 - 279
← 12345 →